Rajpoot, Mukesh, et al. “Safety and Efficacy of Cyclosporine (0.05% Versus 0.09%) in Dry Eye Disease. Is It the Strength of Cyclosporin That Really Matters? ”. Nepalese Journal of Ophthalmology, vol. 14, no. 2, Dec. 2022, pp. 64-77, doi:10.3126/nepjoph.v14i2.38928.